NEW YORK (GenomeWeb) – Qiagen announced on Sunday that it has acquired the enzyme solutions unit of Enzymatics, a supplier of enzymes used in next-generation sequencing and other genetic analysis technologies in life sciences research and clinical applications, for an undisclosed amount.

Qiagen said that it expects the privately held firm to provide approximately $20 million of incremental net sales and to be accretive by approximately $.01 to its adjusted diluted EPS in fiscal year 2015.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Polygamy amplified a rare genetic disease in area near Arizona-Utah border, BBC Future reports.

Genetic ancestry testing led one woman to learn that her father and another baby boy had been switched at birth, the Washington Post reports.

Simple de-identification methods can protect information in a database from attackers, a new study suggests.

In Science this week: approach to visualize chromatin structure in nuclei, and more.

Sponsored by

This webinar will address improvements in the library prep workflow for small RNA sequencing in serum and plasma.

Sponsored by

This webinar will demonstrate a new approach that combines precise FFPE tumor isolation with extraction-free DNA/RNA library preparation to minimize material losses and reduce the amount of tissue input required for NGS analysis.